USPTO serial 76371750
POWER PAPER
Reviewed by CopyMark Law Group
Reg. 2952261Status 710
- Filing date
- Status date
- Registration date
- May 17, 2005
- Examiner
- SPRUILL, DARRYL M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with POWER PAPER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
KIBBUTZ EINAT, IL
KIBBUTZ EINAT, IL
KIBBUTZ EINAT, IL
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
YEHUDA RAMM
WARREN A SKLAR RENNER, OTTO, BOISSELLE & SKLAR19TH FL 1621 EUCLID AVECLEVELAND, OH 44115UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | medical, pharmaceutical and health care products, namely, dermatologicals; medicated skin care preparations; adhesive bandages, containing pharmaceuticals for the treatment of-- rosacea, melasma, acne, skin dryness, rash, cellulite, telangiectasia, aging skin, wrinkles, hyperpigmentation, freckles, puffy eyes, scaly skin, couperose, psoriasis, dermatoses, dermatitis, dermatophytosis, ichthyosis, candidiasis, onychomycosis, tinea, tinea unguium basal cell carcinoma, squamous cell carcinoma, actinic keratosis, warts, scars, keloids, pimples, saborrheic dermatitis for transmdermal application and adhesive bandages for transdermally administering pharmaceutical preparations for the treatment of rosacea, melasma, acne, skin dryness, rash, cellulite, telangiectasia, aging skin, wrinkles, hyperpigmentation, freckles, puffy eyes, scaly skin, couperose, psoriasis, dermatoses, dermatitis, dermatophytosis, ichthyosos, candidiasis, onychomycosis, tinea, tinea unguium, basal cell carcinoma, squamous cell carcinoma, actinic keratosis, warts, scars, keloids, pimples and saborrheic dermatitis; medical plasters impregnated with transdermally active pharmaceutical active preparations for the treatment of rosacea, melasma, acne, skin dryness, rash, cellulite, telangiectasia, aging skin, wrinkles, hyperpigmentation, freckles, puffy eyes, scaly skin, couperose, psoriasis, dermatoses, dermatitis, dermatophytosis, ichthyosos, candidiasis, onychomycosis, tinea, tinea unguium, basal cell carcinoma, squamous cell carcinoma, actinic keratosis, warts, scars, keloids, pimples and saborrheic dermatitis; skin patches, for the transdermal delivery of pharmaceuticals, for the treatment of rosacea, melasma, acne, skin dryness, rash, cellulite, telangiectasia, aging skin, wrinkles, hyperpigmentation, freckles, puffy eyes, scaly skin, couperose, psoriasis, dermatoses, dermatitis, dermatophytosis, ichthyosos, candidiasis, onychomycosis, tinea, tinea unguium, basal cell carcinoma, squamous cell carcinoma, actinic keratosis, warts, scars, keloids, pimples and saborrheic dermatitis; adhesive patches for application to the skin for the treatment of rosacea, melasma, acne, skin dryness, rash, cellulite, telangiectasia, aging skin, wrinkles, hyperpigmentation, freckles, puffy eyes, scaly skin, couperose, psoriasis, dermatoses, dermatitis, dermatophytosis, ichthyosos, candidiasis, onychomycosis, tinea, tinea unguium, basal cell carcinoma, squamous cell carcinoma, actinic keratosis, warts, scars, keloids, pimples and saborrheic dermatitis; adhesive patches for medical purposes for the treatment of rosacea, melasma, acne, skin dryness, rash, cellulite, telangiectasia, aging skin, wrinkles, hyperpigmentation, freckles, puffy eyes, scaly skin, couperose, psoriasis, dermatoses, dermatitis, dermatophytosis, ichthyosos, candidiasis, onychomycosis, tinea, tinea unguium, basal cell carcinoma, squamous cell carcinoma, actinic keratosis, warts, scars, keloids, pimples and saborrheic dermatitis; adhesive skin patches for medical use for the treatment of rosacea, melasma, acne, skin dryness, rash, cellulite, telangiectasia, aging skin, wrinkles, hyperpigmentation, freckles, puffy eyes, scaly skin, couperose, psoriasis, dermatoses, dermatitis, dermatitis, dermatophytosis, ichthyosos, candidiasis, onychomycosis, tinea, tinea unguium, basal cell carcinoma, squamous cell carcinoma, actinic keratosis, warts, scars, keloids, pimples and saborrheic dermatitis; adhesive wound, burn and surgical dressings for application to the skin; adhesive wound, burn and surgical dressings for medical purposes; adhesive skin wound, burn and surgical dressings for medical use; wound, burn and surgical dressings incorporating a pharmaceutical preparation for application to the skin for the treatment of dermatological disorders, leg ulcers, pressure sores, lesions, skin grafts, carcinoma and scarring; adhesive medicated dressings incorporating a pharmaceutical preparation for application to the skin for the treatment for tissue retention and support for management of muscle and ligament disorders and injuries, varicose veins, venous insufficiency and limb compression; wound, burn and surgical dressings for the transdermal delivery of pharmaceuticals for the treatment of tissue retention and support for management of muscle and ligament disorders and injuries, varicose veins, venous insufficiency and limb compression; transdermal wound, burn and surgical dressings | SECTION 8 - CANCELLED | Sep 3, 2004 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 23, 2011 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| May 17, 2005 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 14, 2005 | REGV | LAW OFFICE REGISTRATION REVIEW COMPLETED | — |
| Mar 14, 2005 | ALIE | ASSIGNED TO LIE | — |
| Mar 4, 2005 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Mar 1, 2005 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Feb 14, 2005 | IUAF | USE AMENDMENT FILED | — |
| Feb 14, 2005 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Aug 27, 2004 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Aug 13, 2004 | CFIT | CASE FILE IN TICRS | — |
| Aug 9, 2004 | EXT2 | SOU EXTENSION 2 FILED | — |
| Aug 9, 2004 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 9, 2004 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 15, 2004 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 15, 2004 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 15, 2004 | PAPER RECEIVED | — | |
| Aug 19, 2003 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 30, 2003 | PAPER RECEIVED | — | |
| May 27, 2003 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 7, 2003 | NPUB | NOTICE OF PUBLICATION | — |
| Apr 2, 2003 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 29, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 29, 2003 | PAPER RECEIVED | — | |
| Aug 29, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 31, 2002 | DOCK | ASSIGNED TO EXAMINER | — |
| May 20, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 16, 2002 | DOCK | ASSIGNED TO EXAMINER | — |